InsidersTradesSigma
以岭药业: management transactions · France · AMF
SZSE:002603FR·AMFMcap 28.5Bn€
Browse the full directors' dealings record of 以岭药业, a listed equity based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €28.5bn. The latest transaction was reported on 5 May 2023 (Sale). Among the most active insiders: 张秋莲. Every trade is openly available.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
16.35 €
Income statement
Revenue7.83 Bn€
Gross profit5.03 Bn€64% margin
Net income1.29 Bn€16.4% margin
Balance sheet & cash
Market cap28.52 Bn€
Total debt25.7 M€
Free Cash Flow1.53 Bn€
Last declaration on 5 May 2023
Declarations0 total
No declarations found
0 of 0 declarations